Blackman Samuel C.'s Form 4 filing
Day One Biopharmaceuticals, Inc. (DAWN) · filed Mar 13, 2024
- Accession no.
- 0001415889-24-007810
- Filed
- Mar 13, 2024
- Trade date
- Mar 11, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $457.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blackman Samuel C.CIK 0001863676 | Officer (HEAD OF R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Common Stock | SSaleDisposed | −30,000 | $15.24 | −$457,200 | 1,194,662 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.